107 related articles for article (PubMed ID: 6997386)
1. Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum.
Lanier LL; Babcock GF; Raybourne RB; Arnold LW; Warner NL; Haughton G
J Immunol; 1980 Oct; 125(4):1730-6. PubMed ID: 6997386
[No Abstract] [Full Text] [Related]
2. Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen.
Haughton G; Lanier LL; Babcock GF; Lynes MA
J Immunol; 1978 Dec; 121(6):2358-62. PubMed ID: 82581
[TBL] [Abstract][Full Text] [Related]
3. Antigen-induced murine B-cell lymphomas. III. Passive anti-idiotype serum therapy and its combined effect with chemotherapy.
Lanier LL; Babcock GF; Lynes MA; Haughton G
J Natl Cancer Inst; 1979 Dec; 63(6):1417-22. PubMed ID: 316036
[No Abstract] [Full Text] [Related]
4. Antiidiotype antibody therapy of B-cell lymphoma.
Brown SL; Miller RA; Levy R
Semin Oncol; 1989 Jun; 16(3):199-210. PubMed ID: 2658083
[No Abstract] [Full Text] [Related]
5. Involvement of innate and induced anti-idiotypic mechanisms in suppression of B cell tumors.
Stevenson FK; George AJ; Tutt AL; Glennie MJ; Stevenson GT
Monogr Allergy; 1987; 22():184-93. PubMed ID: 3501833
[No Abstract] [Full Text] [Related]
6. [Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody].
Kon S
Gan To Kagaku Ryoho; 1988 May; 15(5):1685-92. PubMed ID: 3259417
[TBL] [Abstract][Full Text] [Related]
7. The immunobiology of B cell lymphoma: clonal heterogeneity as revealed by anti-idiotype antibodies and immunoglobulin gene probes.
Levy R; Meeker T; Lowder J; Levy S; Thielemans K; Warnke RA; Cleary ML; Sklar J
Symp Fundam Cancer Res; 1986; 38():261-8. PubMed ID: 3529276
[No Abstract] [Full Text] [Related]
8. Cytotoxic effect of anti-idiotype antibody-chlorambucil conjugates against human lymphoblastoid cells.
Tung E; Goust JM; Chen WY; Kang SS; Wang IY; Wang AC
Immunology; 1983 Sep; 50(1):57-64. PubMed ID: 6350169
[TBL] [Abstract][Full Text] [Related]
9. Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation.
Stevenson FK; Gordon J
J Immunol; 1983 Feb; 130(2):970-3. PubMed ID: 6600259
[TBL] [Abstract][Full Text] [Related]
10. Anti-idiotype antibodies reveal the existence of somatic mutation in human B cell lymphoma.
Levy R; Levy S; Brown SL; Kon S; Carroll W
Monogr Allergy; 1987; 22():194-203. PubMed ID: 3325832
[No Abstract] [Full Text] [Related]
11. Expression of 2 immunoglobulin isotypes, IgM and IgA, with identical idiotype in the B cell lymphoma I.29.
Sitia R; Rubartelli A; Hammerling U
J Immunol; 1981 Oct; 127(4):1388-94. PubMed ID: 6974189
[No Abstract] [Full Text] [Related]
12. Surface immunoglobulin of B-lymphocytic tumours as a therapeutic target.
Stevenson GT; Glennie MJ
Cancer Surv; 1985; 4(1):213-44. PubMed ID: 3916080
[TBL] [Abstract][Full Text] [Related]
13. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells.
King CA; Wills MR; Hamblin TJ; Stevenson FK
Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of endotoxin tolerance. 8. Specificity of serum transfer.
Greisman SE; Young EJ; DuBuy B
J Immunol; 1973 Nov; 111(5):1349-60. PubMed ID: 4583074
[No Abstract] [Full Text] [Related]
15. Treatment of lymphoid tumors with anti-idiotype antibodies.
Stevenson GT; Stevenson FK
Springer Semin Immunopathol; 1983; 6(1):99-115. PubMed ID: 6351310
[No Abstract] [Full Text] [Related]
16. Idiotype and antigen-specific T cell responses in mice on immunization with antigen, antibody, and anti-idiotypic antibody.
Mitra-Kaushik S; Shaila MS; Karande AK; Nayak R
Cell Immunol; 2001 May; 209(2):109-19. PubMed ID: 11446743
[TBL] [Abstract][Full Text] [Related]
17. Maternal Ig mediates neonatal tolerance in rheumatoid factor transgenic mice but tolerance breaks down in adult mice.
Wang H; Shlomchik MJ
J Immunol; 1998 Mar; 160(5):2263-71. PubMed ID: 9498766
[TBL] [Abstract][Full Text] [Related]
18. Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined V(L)/V(H) determinants.
Benvenuti F; Burrone OR
Gene Ther; 2001 Oct; 8(20):1555-61. PubMed ID: 11704816
[TBL] [Abstract][Full Text] [Related]
19. Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.
Bohlen H; Thielemanns K; Tesch H; Engert A; Wolf HJ; van Camp B; Urbain J; Diehl V
Cytokines Mol Ther; 1996 Dec; 2(4):231-8. PubMed ID: 9384709
[TBL] [Abstract][Full Text] [Related]
20. Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations.
de Re V; Simula MP; Pavan A; Garziera M; Marin D; Dolcetti R; de Vita S; Sansonno D; Geremia S; Toffoli G
Ann N Y Acad Sci; 2009 Sep; 1173():152-60. PubMed ID: 19758144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
